Clene Inc. — Investor Relations & Filings
Filings indexed
633
across all filing types
Latest filing
2026-05-05
Prospectus
Country
US
United States of America
Listing
US
CLNN
Clene Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing nanotherapeutics to treat neurodegenerative diseases. The company's approach centers on its proprietary technology platform, which creates clean-surfaced, catalytically-active nanocrystals. These nanotherapeutics are designed to address cellular energy impairments, a key factor in the progression of many neurological conditions. By targeting these bioenergetic deficits, Clene aims to restore and protect neuronal health and function. The company is advancing a pipeline of drug candidates to address high unmet medical needs in diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | |
| 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | |
| 8-K - Clene Inc. (0001822791) (Filer) | 2026-05-04 | English | |
| 10-K - Clene Inc. (0001822791) (Filer) | 2026-03-17 | English | |
| 8-K - CLENE INC. (0001822791) (Filer) | 2026-02-24 | English | |
| 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41552311 | 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | ||
| 41541458 | 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | ||
| 40890003 | 8-K - Clene Inc. (0001822791) (Filer) | 2026-05-04 | English | ||
| 32963513 | 10-K - Clene Inc. (0001822791) (Filer) | 2026-03-17 | English | ||
| 32899074 | 8-K - CLENE INC. (0001822791) (Filer) | 2026-02-24 | English | ||
| 32899066 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899067 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899068 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899069 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899072 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899070 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899071 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899073 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 31904864 | 4 Filing | 2026-02-05 | English | ||
| 31904869 | 4 Filing | 2026-02-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Clene Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34487/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34487 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34487 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34487 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34487}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Clene Inc. (id: 34487)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.